Indefinite Delivery Contract 75N95023D00022

The National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), has awarded an Indefinite Delivery Contract (IDC) to Actuated Medical, Inc., doing business as Piezo Resonance Innovations Inc. The $35 million, single-award IDC runs through September 2028 and is for research and development services related to biocompatibility testing, animal studies, and sterilization testing in support of NIDA's Blueprint MedTech (BPMT) Initiative. This work involves providing critical early-stage research resources to NIDA grantees developing novel medical technologies for diagnosing or treating nervous system disorders. The contract enables Actuated Medical to issue task orders for services such as biocompatibility assessments, good laboratory practice animal testing, sterilization validation, and shelf life testing. This supports NIDA's efforts to advance emerging medical devices by de-risking the development process and preparing technologies for potential commercialization. The original solicitation was issued as a Pre-Solicitation Notice, seeking proposals from vendors capable of providing these specialized research services to BPMT program participants. There is no set-aside designation for the contract, and the work will be performed at Actuated Medical's facilities in Bellefonte, Pennsylvania.